LCX Chlamydia Trachomatis Assay
FDA 510(k) K934622 · Abbott Laboratories
510(k) numberK934622
Submission
- Device name
- LCX Chlamydia Trachomatis Assay
- Applicant
- Abbott Laboratories
Abbott Park, IL, US - Received
- September 27, 1993
- Decision date
- December 8, 1995
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MKZ – Dna Probe, Nucleic Acid Amplification, Chlamydia
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 866.3120
- Specialty
- Microbiology
Other 510(k)s with product code MKZ
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K230451 | Aptima® Chlamydia trachomatis AssayMKZ · Traditional | Hologic, Inc. | 11/16/2023SE |
| K140446 | BD Probetec Chlamydia Trachomatis (CT) QX Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 05/20/2014SE |
| K110923 | Cobas 4800 CT / NG TestMKZ · Traditional | Roche Molecular Systems, Inc. | 01/24/2012SE |
| K091724 | BD Probetec Chlamydia Trachomatis (CT) Q Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 11/13/2009SE |
| K090824 | BD Probetec Chlamydia Trachomatis (CT) QX Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 06/02/2009SE |
| K081824 | BD Probetec Chlamydia Trachomatis (CT) Q Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 12/11/2008SE |
| K080739 | Abbott Realtime Ct/Ng Assay and Multi-Collect Specimen Collection KitMKZ · Traditional | Abbott Molecular, Inc. | 07/10/2008SE |
| K070174 | Amplicor Ct/Ng Test for Chlamydia Trachomatis; Roche Scripts for Ct/Ng Test AccessoryMKZ · Traditional | Roche Diagnostics Corporation | 04/16/2007SE |
| K063451 | Gen-Probe Aptima Assay for Chlamydia Trachomatis, Model 1199MKZ · Traditional | Gen-Probe, Inc. | 01/22/2007SE |
| K061413 | Aptima CT Assay on the Tigris DTS SystemMKZ · Traditional | Gen-Probe, Inc. | 10/13/2006SE |
More from Gen-Probe, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K252424 | Anti-HCV NextMZO · Traditional | 04/28/2026SE |
| K243500 | ARCHITECT iGentamicinLCD · Special | 07/09/2025SE |
| K243168 | Alinity i Rubella IgGLFX · Traditional | 06/20/2025SE |
| K243283 | Alinity h-series SystemGKZ · Traditional | 02/20/2025SE |
| K233932 | Alinity i Toxo IgMLGD · Traditional | 08/30/2024SE |
| K232669 | TbiQAT · Special | 09/29/2023SE |
| K222850 | HAVAb IgG IILOL · Traditional | 08/10/2023SE |
| K220031 | Alinity h-series SystemGKZ · Traditional | 08/04/2023SE |
| K220282 | i-STAT PTplus Cartridge with the i-STAT 1 SystemGJS · Traditional | 07/14/2023SE |
| K230937 | Alinity i Total ß-hCG Reagent Kit, GLP systems TrackDHA · Traditional | 06/05/2023SE |
Questions and answers
When was LCX Chlamydia Trachomatis Assay cleared by the FDA?
LCX Chlamydia Trachomatis Assay (K934622) received a 510(k) decision of Substantially Equivalent on December 8, 1995, 802 days after the submission was received.
What is the product code of K934622?
The FDA product code is MKZ – Dna Probe, Nucleic Acid Amplification, Chlamydia, a Class I (low risk) device regulated under 21 CFR 866.3120.